
Last 4 earnings calls · through Q2 FY2026
Half of sales now come from healthcare and water, where medical packaging and procedure volumes support steadier growth than the industrial businesses.
Productivity programs and portfolio simplification aim to lift margins without needing stronger demand, which reduces how much the result depends on the industrial cycle.
With the separations done and debt repaid, management can fund buybacks and small acquisitions out of cash flow without stretching the balance sheet.
Every quarter this year has come in ahead of guidance and the full-year outlook has been raised twice, which supports the case that the portfolio is run more tightly now.
Logistics disruption and shifting desalination project timing showed how much of the water business depends on events in the Middle East that management cannot control.
About a quarter of sales is tied to construction markets that have fallen for several years, and the plan assumes they stop falling rather than that they recover.
Part of the second-half improvement comes from price increases that only match higher oil and gas costs, so volumes carry less of the growth than the headline suggests.
Reported cash generation ran well below the prior year, while the conversion figures management highlights exclude costs related to the separations and transactions.
In short: Healthcare and water grow steadily, but project timing and construction demand remain outside its control.
In February management guided to about 3% organic growth for 2026; by August it expected slightly ahead of 4%, with profit guidance raised alongside. That supports the case that the portfolio can outgrow its end markets.
In May management still expected water to grow mid-single digits for the year; in August it guided to low to mid-single digits, citing Middle East project timing. The revision came one quarter after the previous one.
Management expects about 6% organic growth in the second half, and roughly two points of that is pricing taken to cover oil and gas costs rather than extra volume.
In short: Productivity is lifting gross margin and debt is low, while oil and gas costs weigh on reported cash flow.
Gross margin reached 35.1%, up half a point, helped by productivity that took about 200 basis points out of cost of goods in the second quarter, worth roughly 100 basis points of margin.
Net debt is $1.4 billion against $5.3 billion a year earlier and leverage sits below the 2x target, leaving room for buybacks and the acquisitions management is reviewing.
Management has about $90 million of pricing in the plan to cover higher oil and gas costs, sized to be dollar neutral. The added cost therefore still weighs on the margin rate.
Free cash flow was $283 million over the last twelve months, 4% of revenue, against $812 million a year earlier. The conversion figures management cites are adjusted for transaction costs.
In short: DuPont leads in water filtration and chip-grade water, but construction and Middle East exposure drive swings.
DuPont is the leading supplier of reverse osmosis membranes, ion exchange resins and ultrafiltration, and management says getting bigger through filtration deals would be hard on regulatory grounds. That limits how fast rivals can consolidate.
Sales used to make ultra-pure water for semiconductor plants have grown more than 20% for several quarters, tying part of the water business to chip and data center investment rather than to construction.
Roughly a quarter of revenue sits in construction-linked products that were guided to flat markets in 2026 after a year of declines, so the segment assumes stabilization rather than growth.
About $300 million of revenue either ships into the Middle East or is sourced there, so shipping disruption affects both what DuPont can sell and the materials it can buy.